BPD (Borderline Personality Disorder) is a mental health disorder that affects approximately 1.6% of adults in the United States. It is characterized by difficulties in regulating emotions and behavior, as well as unstable relationships and self-image. One common symptom of…
Borderline personality disorder (BPD) is a mental health condition that affects about 1-3% of the population. It is characterized by unstable moods, impulsive behavior, and difficulty maintaining relationships. One of the lesser-known symptoms of BPD is executive dysfunction, which can…
Bottneuro is a relatively new and emerging concept that combines the fields of biology, neuroscience, and artificial intelligence to study the brain and its functions. It is a multidisciplinary approach that seeks to unravel the mysteries of the brain by…
Bipolar disorder is a mental health condition that affects approximately 2.8% of the U.S adult population. It is characterized by extreme shifts in mood, energy, and behavior, causing significant disruptions in daily life. While most people are familiar with the…
Bipolar disorder is a mental health condition that affects approximately 4.4% of adults in the United States. It is characterized by extreme mood swings, from episodes of mania to periods of depression. These mood changes can greatly impact an individual’s…
Bipolar disorder is a mental health condition that affects approximately 2.8% of the US population, according to the National Institute of Mental Health. This disorder is characterized by extreme mood swings and changes in energy levels, behavior, and thinking. People…
Bipolar disorder, also known as manic depression, is a mental health condition characterized by extreme shifts in mood, energy levels, and behavior. It affects approximately 2.8% of the adult population in the United States and is a lifelong condition that…
Biogen and Eisai are two pharmaceutical companies that have joined forces to make groundbreaking advancements in the field of medicine. These two companies have a long history of success and innovation, and their partnership is set to bring about even…
Dementia is a progressive and debilitating condition that affects millions of people worldwide. It is a term used to describe a wide range of symptoms that are associated with a decline in cognitive function and memory loss. One type of…
Atuzaginstat, also known as VBP15, is a novel drug that has generated a lot of interest and excitement in the medical world. This drug is currently under development by ReveraGen BioPharma with the aim of treating various inflammatory and immune-related…